Top Stories

The Auckland hospital is offering optoms and students the opportunity to observe eyecare to fund its team's CPD.

Luxturna rival emerges

Staff reporters 12/04/2024

Promising interim results from the phase 2 trial of Beacon Therapeutics' gene therapy to treat RP present a challenger to Luxturna.

O-Show, Super Sunday converge on Sydney

Staff reporters 15/04/2024

Nearly at capacity, O-Show 2024 is gearing up for a busy event from 17-18 May at Sydney’s Hordern Pavilion.

Glasses can be highly gender-specific, making some patients feel uncomfortable shopping for them.


Iconic shapes, delicate designs

Staff reporters 20/04/2024

Zeiss strengthens myopia focus

Staff reporters 19/04/2024

ODA offers Kiwi DOs CPD

Staff reporters 19/04/2024

Optos announces key milestones

Staff reporters 18/04/2024

Zeiss simplifies refraction

Staff reporters 18/04/2024

Ethical brand Arhlo unveiled

Staff reporters 17/04/2024

New dry eye disease drug?

Staff reporters 17/04/2024

Alzheimer’s drug lowers AMD risk?

Staff reporters 16/04/2024

Editor's Choice

Addressing staffing gaps with a virtual CFO

David Pearson and Michael Nes 12/04/2024

Uveitis research review

Dr Jo Sims 02/04/2024

Current state of keratoconus management in New Zealand

By Drs Lize Angelo and Akilesh Gokul 01/04/2024

Myopia management applications

Grant Hannaford 14/03/2024


ANZGS: the cutting edge of glaucoma care

Dr Dan Gosling 19/04/2024

DMO: looking beyond HbA1c

Dr Leo Sheck 11/04/2024

Interventional glaucoma: the future is now

Drs Divya Perumal and Shenton Chew 09/04/2024

RANZCO NZ 2024 – meet the speakers

Drew Jones 08/04/2024